Evidence map›Paper›PMID 37606011›Full record

ArticleTurkish journal of pharmaceutical sciences2023

Formulation, Characterization, and Optimization of a Topical Gel Containing Tranexamic Acid to Prevent Superficial Bleeding:

Farideh Shiehzadeh, Daryosh Mohebi, Omid Chavoshian, Sara Daneshmand

Abstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Farideh ShiehzadehZabol University of Medical Sciences, Faculty of Pharmacy, Department of Pharmaceutics, Zabol, Iran.ORCID 0000-0001-7274-0663
Daryosh MohebiZabol University of Medical Sciences, Faculty of Pharmacy, Department of Pharmaceutics, Zabol, Iran.ORCID 0000-0002-7933-9685
Omid ChavoshianMashhad University of Medical Sciences, Pharmaceutical Technology Institute, Nanotechnology Research Center, Mashhad, Iran.ORCID 0000-0002-7635-8952
Sara DaneshmandZabol University of Medical Sciences, Faculty of Pharmacy, Department of Pharmaceutics, Zabol, Iran.ORCID 0000-0001-7474-0157

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Tranexamic acid (TXA) is used systemically to stop bleeding, but it can lead to thromboembolism. Trials have revealed the efficacy of topical TXA on local hemorrhages. However, there is a need for an efficient delivery system that can keep the drug at the site of action. Materials and Methods: To develop a gel containing TXA (3%) optimized in terms of viscosity and dispersibility, the central composite design based on two factors-three levels [carbopol 940 and hydroxypropyl methylcellulose (HPMC), 1-1.5% and 1-2%, respectively] was applied. The spreadability and viscosity were assessed using glass slide and rheometer, respectively. To confirm the compatibility of TXA with the gel, fourier transform-infrared (FTIR) spectroscopy was performed. Drug content uniformity was analyzed by a spectroscopy method. An Results: HPMC/carbopol 940 (1:1, Conclusion: The results confirm the importance of further studies on this formulation as a potential medication to stop acute superficial bleeding.

Indexed as

gelhydroxypropyl methylcelluloseTranexamic acid

Identifiers

PMID37606011
PMCPMC10445226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.